相似文献
1
Getting away from glucose: fanning the flames of obesity-induced inflammation.
Nat Med. 2009 Apr;15(4):373-4. doi: 10.1038/nm0409-373.
2
Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.
Nestle Nutr Inst Workshop Ser. 2012;73:49-60; discussion p61-6. doi: 10.1159/000341287. Epub 2012 Oct 29.
3
Associations of Different Adipose Tissue Depots with Insulin Resistance: A Systematic Review and Meta-analysis of Observational Studies.
Sci Rep. 2015 Dec 21;5:18495. doi: 10.1038/srep18495.
4
Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.
Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E906-16. doi: 10.1152/ajpendo.00117.2003.
5
Getting away from glucose: stop sugarcoating diabetes.
Nat Med. 2009 Apr;15(4):372-3. doi: 10.1038/nm0409-372.
6
Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
Eur J Clin Invest. 2011 Jan;41(1):39-44. doi: 10.1111/j.1365-2362.2010.02372.x. Epub 2010 Sep 6.
7
Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
Nutr Metab Cardiovasc Dis. 2012 Feb;22(2):120-6. doi: 10.1016/j.numecd.2010.05.003. Epub 2010 Sep 28.
8
Evidence for the involvement of resistin in inflammation and cardiovascular disease.
Curr Diabetes Rev. 2005 Aug;1(3):227-34. doi: 10.2174/157339905774574392.
9
Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Obesity (Silver Spring). 2010 Apr;18(4):780-7. doi: 10.1038/oby.2009.301. Epub 2009 Oct 1.
10
Risk factors for non-insulin-dependent diabetes mellitus.
J Hypertens Suppl. 1995 Aug;13(2):S73-6. doi: 10.1097/00004872-199508001-00011.
引用本文的文献
1
Evaluation of laboratory findings indicating pancreatitis in healthy lean, obese, and diabetic cats.
J Vet Intern Med. 2025 Jan-Feb;39(1):e17236. doi: 10.1111/jvim.17236. Epub 2024 Nov 15.
2
Update on Biomarkers of Chronic Inflammatory Processes Underlying Diabetic Neuropathy.
Int J Mol Sci. 2024 Sep 27;25(19):10395. doi: 10.3390/ijms251910395.
3
Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes.
Molecules. 2022 Oct 29;27(21):7352. doi: 10.3390/molecules27217352.
4
Inflammatory biomarkers as a part of diagnosis in diabetic peripheral neuropathy.
J Diabetes Metab Disord. 2021 Jan 15;20(1):869-882. doi: 10.1007/s40200-021-00734-1. eCollection 2021 Jun.
5
Small intestine remodeling in male Goto-Kakizaki rats.
Physiol Rep. 2021 Feb;9(3):e14755. doi: 10.14814/phy2.14755.
6
Cardiac Autonomic Neuropathy: A Progressive Consequence of Chronic Low-Grade Inflammation in Type 2 Diabetes and Related Metabolic Disorders.
Int J Mol Sci. 2020 Nov 27;21(23):9005. doi: 10.3390/ijms21239005.
7
Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat.
Oxid Med Cell Longev. 2020 Mar 11;2020:7805393. doi: 10.1155/2020/7805393. eCollection 2020.
8
Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients.
J Eur Acad Dermatol Venereol. 2020 Mar;34(3):533-541. doi: 10.1111/jdv.16004. Epub 2019 Oct 10.
9
ERAPSO: Revealing the High Burden of Obesity in German Psoriasis Patients.
Dermatol Ther (Heidelb). 2019 Sep;9(3):579-587. doi: 10.1007/s13555-019-0314-1. Epub 2019 Jul 11.
10
Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
mBio. 2018 May 22;9(3):e02392-17. doi: 10.1128/mBio.02392-17.
本文引用的文献
1
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes.
Clin Transl Sci. 2008 May;1(1):36-43. doi: 10.1111/j.1752-8062.2008.00026.x.
2
Variations in DNA elucidate molecular networks that cause disease.
Nature. 2008 Mar 27;452(7186):429-35. doi: 10.1038/nature06757. Epub 2008 Mar 16.
3
Genetics of gene expression and its effect on disease.
Nature. 2008 Mar 27;452(7186):423-8. doi: 10.1038/nature06758. Epub 2008 Mar 16.
4
JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity.
Cell Metab. 2007 Nov;6(5):386-97. doi: 10.1016/j.cmet.2007.09.011.
5
Interleukin-1-receptor antagonist in type 2 diabetes mellitus.
N Engl J Med. 2007 Apr 12;356(15):1517-26. doi: 10.1056/NEJMoa065213.
6
Inflammation and insulin resistance.
J Clin Invest. 2006 Jul;116(7):1793-801. doi: 10.1172/JCI29069.
7
Effects of etanercept in patients with the metabolic syndrome.
Arch Intern Med. 2006 Apr 24;166(8):902-8. doi: 10.1001/archinte.166.8.902.
8
IKK-beta links inflammation to obesity-induced insulin resistance.
Nat Med. 2005 Feb;11(2):191-8. doi: 10.1038/nm1185. Epub 2005 Jan 30.
9
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.
J Clin Invest. 2003 Dec;112(12):1821-30. doi: 10.1172/JCI19451.
10
Obesity is associated with macrophage accumulation in adipose tissue.
J Clin Invest. 2003 Dec;112(12):1796-808. doi: 10.1172/JCI19246.
Zotero 插件